In T2D, hyperinsulinemia is frequently featured because insulin target tissues are unable to perform glucose-lowering responses at normal plasma insulin levels, resulting in increased insulin secretion to compensate [8,9]. The gene discussed is INS; the disease is hyperinsulinism.